Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Novavax Inc. (NVAX)

107.23   -3.95 (-3.55%) 09-29 09:34
Open: 107.7934 Pre. Close: 111.18
High: 109.74 Low: 106.86
Volume: 245,679 Market Cap: 6,571M
Novavax, Inc. is operates as a clinical-stage biotechnology company, which focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. The company is headquartered in Gaithersburg, Maryland and currently employs 379 full-time employees. The firm operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The firm's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The firm's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. The company is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. The company is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 118.018 - 118.64 118.64 - 119.168
Low: 105.038 - 105.69 105.69 - 106.244
Close: 110.072 - 111.217 111.217 - 112.192

Technical analysis

as of: 2020-09-28 4:35:45 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 155.11     One year: 181.17
Support: Support1: 102.16    Support2: 83.22
Resistance: Resistance1: 132.80    Resistance2: 155.11
Pivot: 105.01
Moving Average: MA(5): 108.08     MA(20): 104.47
MA(100): 95.35     MA(250): 43.15
MACD: MACD(12,26): -3.01     Signal(9): -4.70
Stochastic oscillator: %K(14,3): 59.65     %D(3): 54.22
RSI: RSI(14): 49.70
52-week: High: 189.40  Low: 3.54  Change(%): 2119.2
Average Vol(K): 3-Month: 746247  10-Days: 555930

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NVAX has closed below upper band by 34.1%. Bollinger Bands are 19.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 28 Sep 2020
Have Insiders Been Buying Novavax, Inc. (NASDAQ:NVAX) Shares This Year? - Simply Wall St

Mon, 28 Sep 2020
Why Novavax Inc. (NVAX)’s Most Recent Report Reveals Some Hints About Its Future - The News Heater

Mon, 28 Sep 2020
News Flash: Analysts Just Made A Sizeable Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Forecasts - Yahoo Finance

Thu, 24 Sep 2020
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom - GlobeNewswire

Wed, 16 Sep 2020
Novavax, Inc. (NVAX) Management Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript) - Seeking Alpha

Tue, 15 Sep 2020
Novavax, Inc. (NVAX) Management Presents at Cantor Virtual Global Healthcare Conference (Transcript) - Seeking Alpha

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 61
Shares Float (M) 55
% Held by Insiders 0.36
% Held by Institutions 13.89
Shares Short (K) 8,480
Shares Short P. Month (K) 8,040

Stock Financials

EPS -2.400
EPS Est This Year -0.620
EPS Est Next Year -0.550
Book Value (p.s.) 3.020
Profit Margin -185.63
Operating Margin -184.39
Return on Assets (ttm) -10.3
Return on Equity (ttm) -93.8
Qtrly Rev. Growth 958.6
Gross Profit (p.s.) -1.553
Sales Per Share 0.820
EBITDA (p.s.) -1.451
Qtrly Earnings Growth
Operating Cash Flow (M) 37
Levered Free Cash Flow (M) 29

Stock Valuations

PE Ratio -46.32
PEG Ratio
Price to Book value 36.81
Price to Sales 135.61
Price to Cash Flow 186.56

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.